Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description:

Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled
discussion over the role the federal government plays in facilitating the creation of new
pharmaceuticals for the marketplace. This report explores the issue of whether or not the
substantial federal investment in health-related research and development (R&D) entitles the
public to commensurate consideration in prices charged for any resulting drugs. It is intended
to provide the reader with an understanding of the rationale for government support of R&D
and subsequent efforts to facilitate private sector commercialization of new technologies
generated from such work. Concerns surrounding innovation in pharmaceuticals and
biotechnology are discussed within the broader context of the federal role in facilitating
technological progress.

Creator(s): Schacht, Wendy H
Location(s): United States
Creation Date: June 19, 2000
Partner(s):
UNT Libraries Government Documents Department
Collection(s):
Congressional Research Service Reports
Usage:
Total Uses: 33
Past 30 days: 0
Yesterday: 0
Creator (Author):
Schacht, Wendy H

Specialist in Science and Technology

Publisher Info:
Place of Publication: Washington D.C.
Date(s):
  • Creation: June 19, 2000
Coverage:
Place
United States
Description:

Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled
discussion over the role the federal government plays in facilitating the creation of new
pharmaceuticals for the marketplace. This report explores the issue of whether or not the
substantial federal investment in health-related research and development (R&D) entitles the
public to commensurate consideration in prices charged for any resulting drugs. It is intended
to provide the reader with an understanding of the rationale for government support of R&D
and subsequent efforts to facilitate private sector commercialization of new technologies
generated from such work. Concerns surrounding innovation in pharmaceuticals and
biotechnology are discussed within the broader context of the federal role in facilitating
technological progress.

Physical Description:

26 Pages.

Language(s):
Subject(s):
Partner:
UNT Libraries Government Documents Department
Collection:
Congressional Research Service Reports
Identifier:
Resource Type: Report
Format: Text